Skip to content

Comparative study of the effect of hypnotherapy and Monstrogol capsule on primary dysmenorrhea in girls living in dormitories of Isfahan University of Medical Science in 2022

Comparative study of the effect of hypnotherapy and Monstrogol capsule on primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220203053922N1
Enrollment
72
Registered
2022-03-19
Start date
2022-04-04
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea.

Interventions

Intervention 1: Intervention group: Hypnotherapy. Hypnotherapy will be performed in three sessions of 20 minutes for the experimental group individually.In the first session, hypnotherapy is introduce

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Conscious consent to participate in research Single students living in dormitories Suffering age 25-18 years Having regular menstrual periods Having primary dysmenorrhea for at least two consecutive previous periods No application of complementary medicine methods during the last two months Painful menstruation in most menstrual cycles with a pain score of at least 4 out of 10 according to the Visual Analogue Scale (VAS) during two periodic periods Hypnosis of people

Exclusion criteria

Exclusion criteria: Any known disease of the genital tract Secondary dysmenorrhea History of abdominal or pelvic surgery Endometriosis Tobacco use (cigarettes, hookah and drugs), alcohol Speech, hearing, and mental problems Heart, kidney, respiratory, diabetes, asthma, hypothyroidism or hyperthyroidism, epilepsy and other patients in need of medication Sudden weight loss Special diet (vegetarian) Do professional exercise and intense physical exercises Use of herbs, traditional and complementary medicine during the last two months Psychological problems and diseases requiring medication (bipolar disorder, psychosis, major depression, obsession, borderline disorders, dependent personality disorder, schizoid personality disorder, paranoid personality disorder) based on self-reported research units Having coagulation disorders and taking anticoagulants Existence of depression in the individual based on the score obtained from the DASS21 questionnaire

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: Pain ruler.;Number of pain days. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: Asking the patient.;Bleeding volume. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: PBLAC chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahboobeh Valiani

Esfahan University of Medical Sciences

Mahboobehvaliani@gmail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026